Cargando…

Tetracyclines are Associated with a Reduced Risk of Clostridium difficile Infection: A Systematic Review and Meta-analysis

BACKGROUND: Efforts towards antibiotic stewardship help reduce risk of Clostridium difficile infection (CDI) but there is a need to delineate antibiotic choices to reduce CDI risk. Tetracyclines may be associated with a low risk for CDI but the evidence is conflicting. We conducted a systematic revi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tariq, Raseen, Cho, Janice, Kapoor, Saloni, Orenstein, Robert, Singh, Siddharth, Pardi, Darrell, Khanna, Sahil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631336/ http://dx.doi.org/10.1093/ofid/ofx163.953

Ejemplares similares

Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2018)

2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Saha, Srishti, et al.
Publicado: (2019)

Resolution rates in clinical trials for microbiota restoration for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2023)

Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice
por: Tariq, Raseen, et al.
Publicado: (2017)

Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2021)

1620 Extraintestinal Clostridium difficile infections: A Single Center Experience
por: Gupta, Arjun, et al.
Publicado: (2014)

In reply—Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates
por: Tariq, Raseen, et al.
Publicado: (2021)

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2020)

Outcomes in children with Clostridium difficile infection: results from a nationwide survey
por: Gupta, Arjun, et al.
Publicado: (2016)

Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study
por: Saha, Srishti, et al.
Publicado: (2020)

Effect of peripartum Clostridioides difficile infection on pregnancy and neonatal outcomes: an observational study
por: Saha, Srishti, et al.
Publicado: (2023)

1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study
por: Mische, Sarah, et al.
Publicado: (2018)

Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection
por: Saha, Srishti, et al.
Publicado: (2021)

Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis
por: Choudhury, Arup, et al.
Publicado: (2022)

Clostridioides difficile infection: curbing a difficult menace
por: Khanna, Sahil, et al.
Publicado: (2022)

Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
por: Sehgal, Kanika, et al.
Publicado: (2021)

Fecal microbiota transplant via colonoscopy may be preferred due to intraprocedure findings
por: Cho, Janice M., et al.
Publicado: (2019)

Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection
por: Voth, Elida, et al.
Publicado: (2021)

Successful Response to Microbiota-Based Drug RBX2660 in Patients with Recurrent Clostridium Difficile Infection is Associated with More Pronounced Alterations in Microbiome Profile
por: Khanna, Sahil, et al.
Publicado: (2017)

Community-acquired Clostridium difficile infection: an increasing public health threat
por: Gupta, Arjun, et al.
Publicado: (2014)

1503. Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin Is Associated with Reduced Rates of Recurrence after Primary Clostridium Difficile Infection (CDI)
por: Ford, Christopher, et al.
Publicado: (2019)

A Successful Strategy to Reduce Hospital-Onset Clostridium difficile
por: Bruno-Murtha, Lou Ann, et al.
Publicado: (2017)

531. Reducing Inappropriate Hospital-Acquired Clostridium difficile Diagnoses
por: Duncan, Robert, et al.
Publicado: (2018)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations
por: Khanna, Sahil, et al.
Publicado: (2021)

658. Diagnostic Testing Among Patients with Suspected Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III a Phase 3 Clinical Trial: Implications for Clinical Practice vs Clinical Trials
por: Sims, Matthew, et al.
Publicado: (2021)

A268 RESOLUTION RATES IN OPEN-LABEL VERSUS RANDOMIZED CONTROLLED TRIALS FOR MICROBIOTA RESTORATION FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: AN UPDATED META-ANALYSIS
por: Tariq, R, et al.
Publicado: (2023)

A 10-year Review of Clostridium difficile Infection in Acute Care Hospitals in the United States
por: Luo, Ruihong, et al.
Publicado: (2017)

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections
por: Khanna, Sahil, et al.
Publicado: (2020)

Probiotics to Reduce Clostridium difficile Infection: Clinical Experience in a Tertiary Care Center
por: Box, Maggie, et al.
Publicado: (2017)

515. Estimating the Effect of Proton Pump Inhibitor Stewardship in Reducing Clostridium difficile Transmission
por: Lofgren, Eric, et al.
Publicado: (2018)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

536. Clostridium difficile Colonization in the First Year of Life
por: Clayton, Jason A, et al.
Publicado: (2018)

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T, et al.
Publicado: (2014)

Efficacy of Oral Vancomycin, Oral Metronidazole, or IV Metronidazole Prophylaxis at Reducing the Risk of Clostridium difficile Recurrence
por: O’Connell, Matthew, et al.
Publicado: (2017)

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078
por: Dingle, Kate E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m3smf44313k0h36n1rns6b7v6c